Experimental Drug Targets Overactive Bladder
The experimental drug mirabegron may help improve symptoms and quality of life among the estimated 33 million people who live with overactive bladder (OAB).
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.
